Sacubitril-valsartan in patients with NT-proBNP levels outrange of PARADIGM-HF trial inclusion criteria

被引：0
|
作者：
Mario Galvan Ruiz, M. [1 ]
Fernandez De Sanmamed Giron, M. [1 ]
Singh, M. [1 ]
Groba Marco, M. V. [1 ]
Davila Ramos, M. [2 ]
Lopez Perez, M. [1 ]
Hernandez Meneses, B. [1 ]
Godoy Camacho, C. [1 ]
Martin Lorenzo, P. [1 ]
Cardenes Leon, A. [1 ]
Bujanda Morun, P. [1 ]
Perez Nogales, E. D. [3 ]
Medina Gil, J. M. [3 ]
Caballero Dorta, E. [1 ]
Garcia Quintana, A. [1 ]
机构：
[1] Univ Hosp Dr Negrin, Las Palmas Gran Canaria, Spain
[2] Univ Hosp Nuestra Seora Candelaria, Santa Cruz De Tenerife, Spain
[3] Univ Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P587
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [31] Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared With Enalapril: The Paradigm-HF Study
    Vardeny, Orly
    Claggett, Brian
    Kachadourian, Jessica
    Packer, Milton
    Zile, Michael
    Rouleau, Jean
    Swedberg, Karl
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott D.
    CIRCULATION, 2016, 134
  • [32] Generalizability Of The Paradigm-HF Trial For The Use Of Sacubitril/Valsartan In A Tertiary Care Outpatient Heart Failure Patient Population
    Sackheim, Julia
    Chan, Doris
    Beers, Kelly
    Khan, Hassan
    Papadimitriou, Lampros
    Bloom, Michelle W.
    Butler, Javed
    Skopicki, Hal
    CIRCULATION, 2016, 134
  • [33] Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
    Sokos, George G.
    Raina, Amresh
    VASCULAR HEALTH AND RISK MANAGEMENT, 2020, 16 : 41 - 51
  • [34] SACUBITRIL / VALSARTAN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: COMPARATIVE PROFILE OF NT-PROBNP AND BNP
    Ajello, L.
    Romano, G.
    Agnese, V.
    Bellavia, D.
    Di Gesaro, G.
    Falletta, C.
    La Franca, E.
    Mina, C.
    Storniolo, S.
    Clemenza, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E223 - E224
  • [35] Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Liu, Jiankang
    Packer, Milton
    Desai, Akshay S.
    Lefkowitz, Martin P.
    Rouleau, Jean L.
    Shi, Victor C.
    Zile, Michael R.
    Swedberg, Karl
    Vardeny, Orly
    McMurray, John J., V
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (09) : 1518 - 1524
  • [36] Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial
    O'Meara, Eileen
    Prescott, Margaret F.
    Rouleau, Jean L.
    Chiang, Lu-May
    Solomon, Scott D.
    Swedberg, Karl
    Packer, Milton
    McMurray, John J. V.
    Zile, Michael R.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S29 - S30
  • [37] Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study
    Shi, Victor
    Senni, Michele
    Streefkerk, Hendrik
    Modgill, Vikas
    Zhou, Wenchun
    Kaplan, Allen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 118 - 123
  • [38] Outcomes in patients with and without atrial fibrillation in PARADIGM-HF and effect of sacubitril/valsartan according to atrial fibrillation status
    Mogensen, U.
    Swedberg, K.
    Kober, L.
    Jhund, P.
    Shi, V. C.
    Rouleau, J. L.
    Solomon, S. D.
    Zile, M. R.
    Packer, M.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2016, 37 : 193 - 193
  • [39] EFFECT OF SACUBITRIL/VALSARTAN VS. ENALAPRIL ON CHANGES IN BACKGROUND MEDICAL THERAPY OVER TIME IN THE PARADIGM-HF TRIAL
    Bhatt, Ankeet
    Vaduganathan, Muthiah
    Claggett, Brian
    Liu, Jiankang
    Packer, Milton
    Desai, Akshay S.
    Lefkowitz, Martin
    Rouleau, Jean L.
    Shi, Victor
    Zile, Michael
    Swedberg, Karl
    Vardeny, Orly
    McMurray, John
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1002 - 1002
  • [40] Clinical Implication of Very Low Dose of Sacubitril/valsartan for Patients With Heart Failure With Reduced Ejection Fraction; Beyond PARADIGM-HF and PIONEER-HF Trial
    Kim, Hyoeun
    Oh, Jaewon
    Ha, Jaehyung
    Chun, Kyeong-Hyeon
    Lee, Chan Joo
    Park, Sungha
    Lee, Sang-Hak
    Kang, Seok-Min
    CIRCULATION, 2019, 140
12345